goralatide and rxp 407
goralatide has been researched along with rxp 407 in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cotton, J; Cuniasse, P; Dive, V; Vazeux, G | 1 |
Azizi, M; Corvol, P; Cotton, J; Dive, V; Ezan, E; Gonzales, MF; Junot, C; Michaud, A; Vassiliou, S; Vazeux, G; Yiotakis, A | 1 |
Beau, F; Cotton, J; Czarny, B; Dive, V; Georgiadis, D; Yiotakis, A | 1 |
Badaoui, S; Charrier, S; Corvol, P; Ezan, E; Giroux, S; Michaud, A; Sainteny, F; Vainchenker, W | 1 |
Other Studies
4 other study(ies) available for goralatide and rxp 407
Article | Year |
---|---|
Potency and selectivity of RXP407 on human, rat, and mouse angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Interactions; Growth Inhibitors; Humans; Hydrolysis; Male; Mice; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Rats; Species Specificity; Testis | 2001 |
RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hydrolysis; Indicators and Reagents; Lisinopril; Male; Mice; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Time Factors | 2001 |
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Bradykinin; Dose-Response Relationship, Drug; Drug Stability; Humans; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Substrate Specificity | 2003 |
Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Cells; Bone Marrow; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Female; Hematopoiesis; Hematopoietic Stem Cells; Mice; Mice, Inbred C57BL; Oligopeptides; Peptidyl-Dipeptidase A; Perindopril; Phosphinic Acids; Radiation-Protective Agents; Survival Rate; Whole-Body Irradiation | 2004 |